We are live on ! Find out more
DERM icon

Journey Medical
DERM

17 hedge funds and large institutions have $51.4M invested in Journey Medical in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,381% more capital invested

Capital invested by funds: $3.47M → $51.4M (+$48M)

0% more funds holding

Funds holding: 17 → 17 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

1.1% less ownership

Funds ownership: 15.45% → 14.35% (-1.1%)

57% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 7

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$7.83K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.61K
3
BlackRock
BlackRock
New York
+$526
4
Wells Fargo
Wells Fargo
California
+$4

Top Sellers

Rank Fund Capital Flow
1
BRF
B. Riley Financial
California
-$168K
2
NCM
Nantahala Capital Management
Connecticut
-$25.4K
3
PCM
Perkins Capital Management
Minnesota
-$13.8K
4
WAAG
Wealth Alliance Advisory Group
Kansas
-$10K
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$6.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cerity Partners
1
Cerity Partners
New York
$48.8M – – –
BRF
2
B. Riley Financial
California
$1.22M -$168K -89,899 -10%
PCM
3
Perkins Capital Management
Minnesota
$343K -$13.8K -7,405 -3%
NCM
4
Nantahala Capital Management
Connecticut
$333K -$25.4K -13,639 -6%
AFG
5
American Financial Group
Ohio
$283K – – –
Neuberger Berman Group
6
Neuberger Berman Group
New York
$202K -$6.7K -3,592 -3%
First Manhattan
7
First Manhattan
New York
$55.4K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$46.3K -$817 -438 -1%
Vanguard Group
9
Vanguard Group
Pennsylvania
$33K +$7.61K +4,083 +24%
BRWA
10
B. Riley Wealth Advisors
Florida
$27.1K – – –
Creative Planning
11
Creative Planning
Kansas
$18.5K – – –
WAAG
12
Wealth Alliance Advisory Group
Kansas
$16.9K -$10K -5,376 -33%
AFGAS
13
Allegiance Financial Group Advisory Services
Virginia
$15.7K – – –
BlackRock
14
BlackRock
New York
$13.7K +$526 +282 +3%
TRCT
15
Tower Research Capital (TRC)
New York
$9K -$4.13K -2,214 -29%
UBS Group
16
UBS Group
Switzerland
$6.59K +$7.83K +4,198 New
Wells Fargo
17
Wells Fargo
California
$72 +$4 +2 +5%
Bank of America
18
Bank of America
North Carolina
– -$26 -14 Closed

DERM Hedge Fund Activity: Q1 2023 in Review

17 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Journey Medical (DERM) for Q1 2023, worth a combined $51.4M — up 1,381% from $3.47M a quarter earlier.

Fund positioning in DERM was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 7 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $7.83K. The largest seller was B. Riley Financial, cutting an estimated $168K.

  • 17 institutional investors held Journey Medical (DERM) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $51.4M of Journey Medical stock for Q1 2023, up 1,381% quarter-over-quarter.
  • 1 fund opened new Journey Medical positions in Q1 2023 and 1 closed out, a net change of 0 holders.
  • The largest Journey Medical buyer in Q1 2023 was UBS Group, an estimated $7.83K added.
  • The largest Journey Medical seller in Q1 2023 was B. Riley Financial, an estimated $168K sold.

Based on aggregated 13F filings for Q1 2023.